LEAH COLLINS: Open Payments
NPI 1477129559 · DANVERS, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,716 in 112 payments from 18 companies in 2025. Trend: 2023 $3,779 · 2024 $3,676 · 2025 $2,716
Food & beverage: $2,631Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $675 |
| UCB, Inc. | 5 | $303 |
| Janssen Biotech, Inc. | 16 | $218 |
| Galderma Laboratories, L.P. | 9 | $212 |
| GENZYME CORPORATION | 8 | $207 |
| Incyte Corporation | 10 | $182 |
| Arcutis Biotherapeutics, Inc. | 5 | $161 |
| Lilly USA, LLC | 9 | $148 |
| Novartis Pharmaceuticals Corporation | 4 | $132 |
| PFIZER INC. | 5 | $112 |
Products named: Bimzelx, DUPIXENT, BOTOX, TREMFYA, NEMLUVIO, OPZELURA, SKYRIZI, Zoryve.
Industry payments across MA — which companies pay providers there.
